文献速递血液透析通路

inflow动脉与止血带头静脉直径对预测血液透析动静脉瘘成功使用及通畅性的意义

The Significance of Inflow Artery and Tourniquet Derived Cephalic Vein Diameters on Predicting Successful Use and Patency of Arteriovenous Fistulas for Haemodialysis.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2017-03-18

止血带下头静脉直径<4.3 mm是桡动脉-头静脉AVF次级和功能性次级通畅性的唯一独立预测因子;肱动脉直径≤4.1 mm是肱动脉-头静脉AVF功能性和所有通畅性的独立预测因子。

要点

  • 止血带头静脉直径<4.3 mm预测桡动脉-头静脉AVF次级通畅性差
  • 肱动脉直径≤4.1 mm预测肱动脉-头静脉AVF功能性和通畅性差
  • 下肢PAD或双联抗血栓治疗与次级通畅性差独立相关

核心结论

  • 下肢PAD或双联抗血栓治疗与次级通畅性差独立相关。
  • 风险因素数量(肱动脉直径≤4.1 mm、PAD、双联抗血栓治疗)可对功能性次级通畅性进行风险分层。

研究设计与样本

  • 单中心研究,回顾性分析2010年11月至2015年7月前瞻性收集的数据。

主要发现

  • 下肢PAD或双联抗血栓治疗与次级通畅性差独立相关。

临床怎么用

  • 术前血管测绘应包含止血带头静脉直径和肱动脉直径,以评估AVF通畅性风险。
  • 桡动脉-头静脉AVF术前头静脉直径<4.3 mm时,应预期次级通畅性较差。
  • 肱动脉-头静脉AVF术前肱动脉直径≤4.1 mm时,应预期功能性和所有通畅性较差。
  • 合并下肢PAD或使用双联抗血栓治疗时,应关注次级通畅性风险。

局限性

  • 研究结果需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the significance of inflow artery and cephalic vein diameters on predicting patency of radiocephalic and brachiocephalic arteriovenous fistulas (AVFs). DESIGN: Single centre study with retrospective analysis of prospectively collected data between November 2010 and July 2015. METHODS: A detailed history and physical examination was undertaken, including age, gender, history and duration of haemodialysis, cause of chronic kidney disease, and the presence of comorbidities/risk factors. Pre-operative arterial and venous upper extremity mapping was performed and inner vessel diameter was recorded, using a tourniquet for the veins. Outcome measures included AVF use (functionality), primary, primary assisted, secondary, and functional secondary patency. RESULTS: One hundred and thirty five AVFs (57 and 78 radiocephalic and brachiocephalic AVFs, respectively) were constructed and followed up for 5 years. A cephalic vein diameter <4.3 mm (lower three quartiles) was the single independent predictor of inferior secondary and also functional secondary patency of radiocephalic AVFs (p = .02, HR 11.2, 95% CI 1.44-90.9). A brachial artery diameter ≤4.1 mm (lowest quartile) was an independent predictor of AVF functionality (57% vs. 83% for larger arteries, p = .017), and inferior primary, primary assisted, secondary, and functional secondary patency of brachiocephalic AVFs (primary assisted patency 21.9% vs. 55.9% at 3 years, p = .001/log-rank test, HR 3.1, p = .002/Cox regression). The presence of lower extremity PAD or use of dual antithrombotics was also independently associated with an inferior secondary patency. The number of risk factors (brachial artery diameter ≤4.1 mm, PAD, and use of dual antithrombotics) demonstrated risk stratification capabilities for functional secondary patency. CONCLUSIONS: Among patients undergoing radiocephalic AVFs, a tourniquet derived cephalic vein diameter <4.3 mm was the single independent predictor of inferior secondary and functional secondary patency. Among patients undergoing brachiocephalic AVFs, all patency rates were inferior in the presence of a brachial artery diameter ≤4.1 mm and secondary patency was inferior in the presence of multiple risk factors.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Kakkos SK, Kaplanis N, Papachristou EC, et al. The Significance of Inflow Artery and Tourniquet Derived Cephalic Vein Diameters on Predicting Successful Use and Patency of Arteriovenous Fistulas for Haemodialysis. Eur J Vasc Endovasc Surg. 2017. PMID: 28318999. doi:10.1016/j.ejvs.2017.02.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。